23 May 2017

Verona Pharma to Present at Jefferies 2017 Global Healthcare Conference

LONDON, May 23, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs, announced today that Jan-Anders Karlsson, PhD, CEO of Verona Pharma, is scheduled to present at the Jefferies 2017 Global Healthcare Conference.

An audio webcast of the presentation will be available on the Investors section of the company website, www.veronapharma.com.  A replay of the webcast will be made available for 90 days following the presentation.

Event: Jefferies Healthcare Conference
Date: June 8, 2017
Time: 11:30 AM EDT
Location: New York, NY

For further information, please contact:

Verona Pharma plc           Tel: +44 (0)20 3283 4200
Jan-Anders Karlsson, Chief Executive Officer           info@veronapharma.com 
             
N+1 Singer (Nominated Adviser and UK Broker)           Tel: +44 (0)20 7496 3000
Aubrey Powell / James White            
             
FTI Consulting (UK Media and Investor enquiries)           Tel: +44 (0)20 3727 1000
Simon Conway / Stephanie Cuthbert /
Natalie Garland-Collins
          veronapharma@fticonsulting.com 
             
ICR, Inc. (US Media and Investor enquiries)            
James Heins           Tel: +1 203-682-8251
James.Heins@icrinc.com
             
Stephanie Carrington           Tel. +1 646-277-1282
Stephanie.Carrington@icrinc.com 

Primary Logo

 

Verona Pharma plc

For further information please contact:

 

Verona Pharma plc
Jan-Anders Karlsson, CEO
Victoria Stewart, Director of Communications
Tel: +44 (0)20 3283 4200
info@veronapharma.com

N+1 Singer (Nominated Adviser and UK Broker)
Aubrey Powell /Jen Boorer /Iqra Amin (Corporate Finance)
Brough Ransom /Mia Gardner (Corporate Broking)
Tel: +44 (0)20 3283 4200

 

 

Optimum Strategic Communications
(European Media and Investor enquiries)
Mary Clark, Annemarieke Ezendam
Hollie Vile
Tel: +44 (0) 203 950 9144
verona@optimumcomms.com

Argot Partners (Investor enquiries)
Stephanie Marks
Tel. +1 646 644 9590
verona@argotpartners.com


Close

Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us